Literature DB >> 10755404

Treatment of canine oral squamous cell carcinomas with photodynamic therapy.

D L McCaw1, E R Pope, J T Payne, M K West, R V Tompson, D Tate.   

Abstract

Eleven dogs with naturally occurring oral squamous cell carcinomas were treated with photodynamic therapy (PDT) using Photochlor (HPPH) as the photosensitizer. The largest length of the tumours measured in a two-dimensional plane ranged from 0.9 to 6.8 cm. Seven of the tumours invaded underlying bone as determined by radiograph appearance. Photochlor was injected intravenously at a dose of 0.3 mg kg(-1). Forty-eight hours later the tumours were treated. Tumours with a surface to base depth of greater than 1 cm were surgically reduced to less than 1 cm. Irradiation with 665 nm light with an energy density of 100 J cm(-2) was administered. Eight dogs were considered cured with no tumour recurrence for at least 17 months after treatment. Local treatment of oral squamous cell carcinomas with PDT appears to give results similar to those obtained with surgical removal of large portions of the mandible or maxilla. The cosmetic results with PDT are superior to those of radical surgical removal. The new sensitizer, Photochlor, appears effective for oral squamous carcinomas with results similar to those reported for other sensitizers.

Entities:  

Mesh:

Year:  2000        PMID: 10755404      PMCID: PMC2374488          DOI: 10.1054/bjoc.1999.1094

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer.

Authors:  M L Magne; C O Rodriguez; S A Autry; B F Edwards; A P Theon; B R Madewell
Journal:  Lasers Surg Med       Date:  1997       Impact factor: 4.025

2.  Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity.

Authors:  W E Grant; P M Speight; C Hopper; S G Bown
Journal:  Int J Cancer       Date:  1997-06-11       Impact factor: 7.396

3.  Photodynamic therapy for facial squamous cell carcinoma in cats using Photofrin.

Authors:  C J Chang; Y L Lai; C J Wong
Journal:  Changgeng Yi Xue Za Zhi       Date:  1998-03

4.  Oral and pharyngeal neoplasia in the dog: a retrospective survey of 361 cases.

Authors:  R J Todoroff; R S Brodey
Journal:  J Am Vet Med Assoc       Date:  1979-09-15       Impact factor: 1.936

5.  Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck.

Authors:  B L Wenig; D M Kurtzman; L I Grossweiner; M F Mafee; D M Harris; R V Lobraico; R A Prycz; E L Appelbaum
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-11

6.  Photodynamic therapy for nasal and aural squamous cell carcinoma in cats.

Authors:  A E Peaston; M W Leach; R J Higgins
Journal:  J Am Vet Med Assoc       Date:  1993-04-15       Impact factor: 1.936

7.  Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.

Authors:  D A Bellnier; B W Henderson; R K Pandey; W R Potter; T J Dougherty
Journal:  J Photochem Photobiol B       Date:  1993-09       Impact factor: 6.252

8.  Pharmacokinetics of pyropheophorbide-a-hexyl ether in the dog.

Authors:  J T Payne; D L McCaw; S W Casteel; D Frazier; K Rogers; R V Tompson
Journal:  Lasers Surg Med       Date:  1996       Impact factor: 4.025

9.  A study of the effects of photodynamic therapy on the normal tissues of the rabbit jaw.

Authors:  M Meyer; P Speight; S G Bown
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  9 in total
  2 in total

1.  Lightpipe device for delivery of uniform illumination for photodynamic therapy of the oral cavity.

Authors:  Cristina Canavesi; William J Cassarly; Thomas H Foster; Jannick P Rolland
Journal:  Appl Opt       Date:  2011-06-01       Impact factor: 1.980

2.  Illumination devices for photodynamic therapy of the oral cavity.

Authors:  Cristina Canavesi; Florian Fournier; William J Cassarly; Thomas H Foster; Jannick P Rolland
Journal:  Biomed Opt Express       Date:  2010-11-23       Impact factor: 3.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.